Skip to contentC
Cryo Cell International Inc
C
CCELCryo Cell International Inc Q4 2016 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$5.87M$5.87Mderived+1.3% vs Q4 2015 Net Income$809.37K$809.37KderivedN/M vs Q4 2015 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cryo Cell International Inc · CIK 862692 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived$456,863+3.5% Operating Cash Flowderived$2,563,073+28.9% Free Cash Flowderived$2,518,691+30.2% Margins · derivedOperating margin7.8%+0.2 pt vs Q4 2015
Net margin13.8%+17.6 pt vs Q4 2015
ended Nov 30, 2016 · filed Feb 28, 2017 · 90 d after period end